ADMA
#1975
ADMA Biologics Inc - Common Stock
9.3 4 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.48%
Monthly Change
+8.73%
6 month change
-40.51%
Year Change
-45.35%
Previous Close
9.4 8
Open
9.3 4
Low
9.3 4
High
9.3 4
Volume
178
Financials
- Market Capitalization 2.09 B
- Employee 647
- Founded 2004
- CEO N/A
- Website www.admabiologics.com
- Headquarter Delaware, United States
- FIGI BBG002NCK5M5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
30.4
Price to sales ratio
8.76
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1961 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +6.13% | +129.58% | 2.13 B USD | ||
| 1972 |  VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -12.82% | +12.65% | 2.10 B USD | ||
| 1994 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +6.29% | +59.78% | 2.04 B USD | ||
| 1996 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 31.27 USD | -4.14% | -3.49% | -4.34% | +18.18% | 2.04 B USD |
Frequently asked questions about ADMA Biologics, Inc.
What is the ADMA Biologics, Inc. stock price today?
The current price of ADMA Biologics, Inc. (ADMA) is 9.34. Over the past 24 hours, the stock has changed by -1.48%. Follow the ADMA chart for real-time price dynamics.
What is the stock ticker of ADMA Biologics, Inc.?
ADMA Biologics, Inc. trades under the ticker ADMA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ADMA Biologics, Inc. stock going up?
ADMA has changed by -4.69% over the last week, +8.73% over the last month, and -45.35% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ADMA Biologics, Inc.?
ADMA Biologics, Inc. currently has a market capitalization of 2.09 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ADMA Biologics, Inc. earnings last quarter?
Last quarter, ADMA Biologics, Inc. reported earnings of 0.17 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ADMA Biologics, Inc. revenue for the last quarter?
ADMA Biologics, Inc. reported quarterly revenue of 124.39 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ADMA Biologics, Inc. net income for the last quarter?
ADMA Biologics, Inc. reported net income of 37.82 M for the last quarter. The previous quarter showed 45.33 M, which means net income changed by -16.56%.
How many employees does ADMA Biologics, Inc. have?
As of the latest available data, ADMA Biologics, Inc. has 647 employees. Workforce size can provide additional context about the company's scale and operations.
What is ADMA Biologics, Inc. EBITDA?
ADMA Biologics, Inc. EBITDA is 54.15 M, and its EBITDA margin is 43.53%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ADMA Biologics, Inc. stock?
You can buy ADMA Biologics, Inc. (ADMA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ADMA Biologics, Inc. stock?
Investing in ADMA Biologics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADMA chart and related analysis on metatrader.com as part of your research.